The Borealis-2 clinical trial: A randomized phase 2 study of OGX-427 (Apatorsen) plus docetaxel versus docetaxel alone in relapsed/refractory metastatic urothelial cancer

Authors :: Toni K. Choueiri
Noah M. Hahn
Ajjai Shivaram Alva
Richard C. Lauer
Robert Dreicer
Joel Picus
Roberto Pili
Arjun Vasant Balar
Guru Sonpavde
Jean H. Hoffman-Censits
Elizabeth A. Guancial
Robert Alter
Meredith M. Regan
Cindy Jacobs
Patricia S. Stewart
Sumanta Kumar Pal
Jonathan E. Rosenberg
Source :: Journal of Clinical Oncology. 33:TPS4577-TPS4577
Publication Year :: 2015
Publisher :: American Society of Clinical Oncology (ASCO), 2015.

Tools